Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: Effective clinical downstaging allows breast preservation and predicts outstanding local control and survival

Annals of Surgery

Volumn 236, Issue 3, 2002, Pages 295-303

  Cance, William G ^a,b   Carey, Lisa A ^a   Calvo, Benjamin F ^a   Sartor, Carolyn ^a   Sawyer, Lynda ^c   Moore, Dominic T ^c   Rosenman, Julian ^a   Ollila, David W ^a   Graham II, Mark ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; DEATH; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MENOPAUSE; METASTASIS; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 18544373337     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200209000-00006     Document Type: Conference Paper

References (22)

1. Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer
2. Preoperative (neoadjuvant) chemotherapy in patients with breast cancer
3. Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
4. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma
5. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
6. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy
7. Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy
8. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer
9. Conservation surgery after primary chemotherapy in large carcinomas of the breast
10. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
11. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB)
12. T3b-T4 breast cancer: Factors affecting results in combined modality treatments
13. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
14. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: The University of Michigan experience
15. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer
16. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
17. The effect on primary tumor response of adding sequential Taxotere to Adriamycin and cyclophosphamide: Preliminary results from NSABP Protocol B-27
18. Long-term results of combinedmodality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D Anderson Cancer Center experience
19. Effect of surgical removal on the growth and kinetics of residual tumor
20. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases
21. Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
22. Embolization coils as tumor markers for mammography in patients undergoing neoadjuvant chemotherapy for carcinoma of the breast